FIGURE 5.

Elaboration of a predictive model for immune cells. (A) Identification of seven immune cells utilizing LASSO technique. (B) Incorporation of five immune cells into the predictive model. (C) Demonstration of five predictive cells linked to immune infiltration along with their expression patterns in patients with BLCA having diverse risk scores and distinct survival outcomes. (D) KM curves showcasing the division of participants into high‐ and low‐risk groups. (E) Assessment of the responsiveness of Immune Checkpoint Inhibitors in high‐ and low‐risk groups. (F) Examination of the prognostic significance of five distinct immune cell types through univariate cox regression analysis. (G) Evaluation of the prognostic significance of five distinct immune cell types through multifactorial cox regression analysis. *p < .05.